IL36G and colorectal carcinoma: IL-36γ has also been shown to promote proliferation in HT29 and CT26 (human and murine CRC) [85], HCT116 and MC38 (human and murine CRC) [86], LLC (human NSCLC) [83], and HSC-3 (human oral squamous cell carcinoma) [87] cells.